Sigyn Therapeutics (SIGY) EBITDA Margin (2017 - 2020)
Sigyn Therapeutics (SIGY) posted EBITDA Margin of -5771.67% for Q3 2020, down 5449.65 percentage points from -322.02% a year earlier.
Powered by 
Analysis
Sigyn Therapeutics (SIGY) EBITDA Margin (2017 - 2020) Analysis & Trends
For the trailing twelve months through Sep 30, 2020, EBITDA Margin at Sigyn Therapeutics was -5590.19%, down 5217.68 percentage points year-over-year; for FY2019, it came in at -308.84%, up 2362.66 percentage points from FY2018.
- Annual EBITDA Margin shows a three-year change of -280.87 percentage points (FY2016 to FY2019).
- In prior years, Sigyn Therapeutics' EBITDA Margin was -2671.50% in FY2018 (+1992.41 pp), -4663.91% in FY2017 and -27.97% in FY2016.
- Quarterly EBITDA Margin has run from a low of -24230.03% in Q1 2020 to a high of 290.80% in Q4 2019 over five years.
- On a year-over-year basis, EBITDA Margin increased in two of the last five quarters, with an average year-over-year change of -5195.98 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q2 2019, with a gain of 2844.62 percentage points; the weakest was Q1 2020, with a drop of 23870.70 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 28.17% |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 31.93% |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 24.62% |
| 10 | Sigyn Therapeutics | 64,215.08 | -46,853.92 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | -5,771.67% |
| Mar 31, 2020 | -24,230.03% |
| Dec 31, 2019 | 290.80% |
| Sep 30, 2019 | -322.02% |
| Jun 30, 2019 | -127.41% |
| Mar 31, 2019 | -359.33% |
| Sep 30, 2018 | -198.17% |
| Jun 30, 2018 | -2,972.03% |
| Mar 31, 2018 | -979.04% |
| Sep 30, 2017 | -203.72% |
| Jun 30, 2017 | -128.74% |
| Mar 31, 2017 | -107.40% |
API Access
Sigyn Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SIGY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "SIGY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SIGY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();